Find recruiting clinical trials for eczema and atopic dermatitis in the UK — including moderate to severe disease, biologic therapy, and JAK inhibitor studies. See treatment pathways and where trials fit in.
Free to use — Live data from ClinicalTrials.gov — Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
First-line treatment
Standard: Emollients + topical corticosteroids or calcineurin inhibitors
Not controlled with topicals alone
Standard: Phototherapy (UVB), Dupilumab (Dupixent), or systemic immunosuppression
Severe widespread disease
Standard: Dupilumab, Tralokinumab, or clinical trial
Novel targeted oral therapy
Standard: Abrocitinib, Upadacitinib, or Baricitinib
Eczema affecting large body areas that significantly impacts daily life. About 15-20% of eczema patients have moderate-to-severe disease.
Chronic eczema specifically affecting the hands. Can be disabling, especially for manual workers.
Coin-shaped patches of irritated skin. Often mistaken for ringworm or fungal infection. Can be stubborn to treat.
Loading trials from ClinicalTrials.gov...
JAK inhibitors (Abrocitinib, Upadacitinib, Baricitinib) are oral tablets that target specific immune pathways involved in eczema. They are approved in the UK but trials are exploring new JAK inhibitors and expanded uses.
Yes. Many eczema trials specifically recruit children and adolescents. Dupilumab and some JAK inhibitors have paediatric approvals. Trials for children have additional safety safeguards.
Dupilumab (Dupixent) is a biologic injection approved on the NHS for moderate-to-severe atopic dermatitis. Clinical trials may offer access to newer biologics that work differently or are longer-acting.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.